TY  - JOUR
AU  - Egui, Adriana
AU  - Thomas, M Carmen
AU  - Fernández-Villegas, Ana
AU  - Pérez-Antón, Elena
AU  - Gómez, Inmaculada
AU  - Carrilero, Bartolomé
AU  - Del Pozo, Ángel
AU  - Ceballos, Maialen
AU  - Andrés-León, Eduardo
AU  - López-Ruz, Miguel Ángel
AU  - Gainza, Eusebio
AU  - Oquiñena, Enrique
AU  - Segovia, Manuel
AU  - López, Manuel Carlos
PY  - 2019
DO  - 10.1128/AAC.02436-18
UR  - http://hdl.handle.net/10668/14331
T2  - Antimicrobial agents and chemotherapy
AB  - One of the current greatest challenges of Chagas disease is the establishment of biomarkers to assess the efficacy of drugs in a short period of time. In this context, the reactivity of sera from 66 adults with chronic indeterminate Chagas disease...
LA  - en
KW  - Chagas disease
KW  - Trypanosoma cruzi
KW  - antibodies
KW  - benznidazole
KW  - biomarkers
KW  - cellular response
KW  - cytokines
KW  - cytotoxic molecules
KW  - seroconversion
KW  - therapeutic response
KW  - Adult
KW  - Biomarkers
KW  - CD8-Positive T-Lymphocytes
KW  - Chagas Disease
KW  - Cytokines
KW  - Enzyme-Linked Immunosorbent Assay
KW  - Female
KW  - Granzymes
KW  - Humans
KW  - Male
KW  - Middle Aged
KW  - Nitroimidazoles
KW  - Perforin
KW  - Polymerase Chain Reaction
KW  - Trypanocidal Agents
KW  - Trypanosoma cruzi
KW  - Young Adult
TI  - A Parasite Biomarker Set for Evaluating Benznidazole Treatment Efficacy in Patients with Chronic Asymptomatic Trypanosoma cruzi Infection.
TY  - research article
VL  - 63
ER  -